Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONVEY: Vixotrigine in Small Fiber Neuropathy
NCT03339336Phase 2Terminated
- Sponsor
- Biogen
- Start
- May 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of vixotrigine in small fiber neuropathy (SFN), sponsored by Biogen. Started May 2018; status: terminated.
02
Drugs
vixotrigine
03
Conditions
small fiber neuropathy (SFN)
Beyond the preview
Go deeper on NCT03339336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339336.